NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bonito Biosciences

Bonito Biosciences

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://www.bonitobio.com/

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Bonito Biosciences is a biotechnology company developing a data foundation for programmable oligonucleotide delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Infrastructure

Keywords

drug delivery platformoligotherapeutic deliveryAI drug discoveryRNA deliveryAI biotechligand discoverycentral nervous system deliveryCNS deliverygenerative biologyoligotherapeuticsRNA therapeuticsdrug discovery platformencoded ligand librariesfunctional screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bonito Biosciences Comparables

Compare Bonito Biosciences with similar companies based on industry and business-model similarity.

Bonito Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gensaic
86%
Nosis Bio
85%
Vivatides Therapeutics
78%
View all Comparables

Bonito Biosciences Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Richard Wagner

Chief Executive Officer And Founder

Founding Team

Bonito Biosciences Investors

Notable investors and investment history

Bonito Biosciences investors
InvestorRounds
Lightstone VenturesSeed
JAZZ Venture PartnersSeed
Anterra CapitalSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors increased 203% MoM, reaching 4.5K.

  • Mar 1, 2026

    Monthly visitors grew 75% MoM, from 1K to 1.8K.

View all signals

Bonito Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bonito Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bonito Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range28
Year Founded2022
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.